Filing Details

Accession Number:
0001179110-21-003344
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-12 16:18:34
Reporting Period:
2021-03-10
Accepted Time:
2021-03-12 16:18:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466538 Cowen Inc. COWN Security Brokers, Dealers & Flotation Companies (6211) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477552 Stephen Lasota Cowen Inc.
599 Lexington Avenue
New York NY 10022
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-03-10 45,000 $0.00 273,751 No 4 A Direct
Class A Common Stock Disposition 2021-03-11 14,000 $39.36 259,751 No 4 S Direct
Class A Common Stock Acquisiton 2021-03-10 50 $0.00 259,801 No 4 A Direct
Class A Common Stock Disposition 2021-03-10 6,149 $42.17 253,652 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 A Direct
No 4 F Direct
Footnotes
  1. On March 15, 2016, the Reporting Person was granted a performance share award consisting of 25,000 target shares, with the number of shares to be delivered upon settlement based on the attainment of certain performance metrics. In accordance with the performance share award agreement, 45,000 shares which represented the maximum payout under the performance share award agreement, were settled and delivered to the Reporting Person on March 10, 2021.
  2. Shares sold by the Reporting Person in connection with the payment of taxes related to the settlement of the performance share award referenced in footnote 1.
  3. Grant of Cowen stock for no monetary consideration. The stock award was settled and delivered on March 10, 2021.
  4. Represents shares of the Issuer's Class A common stock withheld to satisfy tax withholding obligations upon the vesting of restricted stock, in accordance with the terms of the related grant agreement, which was approved by the board of directors of the Issuer in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934.